Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial - Concepedia

Concepedia

Publication | Open Access

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial

DOI Full Paper Access

78

Citations

16

References

2014

Year

Juan Carlos Tinoco, Noris Pavía-Ruz, Aurelio Cruz-Valdéz, Carlos Aranza Doniz, Vijayalakshmi Chandrasekaran, Walthère Dewé, Aixue Liu, Bruce L. Innis, Varsha Jain

Abstract

QIV provided superior immunogenicity for the added B strain without affecting the antibody response to the TIV strains, and without compromising safety.

References

	Year	Citations

Page 1